amlodipine has been researched along with telmisartan in 136 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 25 (18.38) | 29.6817 |
| 2010's | 92 (67.65) | 24.3611 |
| 2020's | 19 (13.97) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Stangier, J; Su, CA | 1 |
| de Champlain, J; Lacourcière, Y; Lamarre-Cliche, M; Larochelle, P; Poirier, L | 1 |
| de Champlain, J; Karas, M; Lacourcière, Y; Lamarre-Cliche, M; Larochelle, P; Poirier, L | 1 |
| de Champlain, J; Dubé, B; Florescu, M; Karas, M; Lacourcière, Y; Lamarre-Cliche, M; Larochelle, P; LeBlanc, AR; Nadeau, R; Poirier, L | 1 |
| Maki, K; Morimoto, S; Sawada, K; Yano, Y | 1 |
| Hassan, H; Negro, R | 1 |
| Shimabukuro, M; Shimabukuro, T; Tanaka, H | 1 |
| Derosa, G; Destro, M; Fogari, E; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Rinaldi, A; Zoppi, A | 1 |
| Itoh, Y; Mori, Y; Tajima, N | 1 |
| Bagchi, A; Baliga, VP; Bollmall, C; Kinagi, SB; Sharma, A; Sharma, YK | 1 |
| Itagaki, K; Nakamoto, H; Nishida, E; Ryuzaki, M; Sone, M; Suzuki, H; Yoshimoto, M | 1 |
| Hedner, T; Kjeldsen, SE; Narkiewicz, K; Oparil, S | 1 |
| Inoue, T; Kawagoe, Y; Koide, H; Nakamura, T; Node, K; Suzuki, T; Ueda, Y | 1 |
| Cao, T; Chen, X; Feng, X; He, H; Liu, D; Luo, Z; Ma, L; Tepel, M; Wang, L; Yan, Z; Yang, D; Zhu, Z | 1 |
| Albert, DH; Banfor, PN; Cox, BF; Davidsen, SK; Franklin, PH; Fryer, RM; Gintant, GA; Larson, KJ; Noonan, WT; Segreti, JA; Tapang, P; Widomski, DL | 1 |
| Guthrie, R; Kobe, M; Littlejohn, TW; Majul, CR; Oigman, W; Olvera, R; Seeber, M | 2 |
| Faruqui, AA | 1 |
| Fu, L; Mao, ZX; Wang, J; Wang, SL; Zhang, J; Zheng, TR | 1 |
| Ando, K; Isshiki, M; Takahashi, K | 1 |
| Cao, T; Chen, X; Feng, X; He, H; Liu, D; Luo, Z; Ma, L; Ma, S; Tepel, M; Yan, Z; Yang, D; Zhu, Z | 1 |
| Deng, Q; Huang, J; Li, W; Lin, SG; Liu, LS; Liu, MB; Ma, LY; Wang, W; Zhang, YQ; Zhu, DL | 1 |
| Cheng, XM; Chu, WW; Du, M; Li, Y; Ma, SM | 1 |
| Deng, Q; Liu, L; Liu, M; Ma, L; Wang, W; Zhang, Y | 1 |
| Arif, AF; Joshi, C; Kadam, GG | 1 |
| Ahrens, K; Bramlage, P | 1 |
| Littlejohn, TW; Majul, CR; Mancia, G; Oigman, W; Olvera, R; Schumacher, H; Seeber, M; White, WB | 1 |
| Chen, C; Ding, G; Hu, F; Liang, W; Ren, Z; Shi, J; Singhal, PC; van Goor, H | 1 |
| Bilo, G; Mancia, G; Parati, G; Schumacher, H | 1 |
| Moen, MD | 1 |
| Gismondi, RA; Neves, MF; Oigman, W | 1 |
| Arfanakis, DA; Chlouverakis, G; Kochiadakis, GE; Kontaraki, JE; Marketou, ME; Parthenakis, F; Tsakountakis, NA; Vardas, PE; Zacharis, EA | 1 |
| Comi-Diaz, C; Macias-Batista, A; Martinez-Martin, FJ; Pedrianes-Martin, P; Rodriguez-Rosas, H; Soriano-Perera, P | 1 |
| Gu, XF; Liu, AJ; Liu, W; Ma, XJ; Song, SW; Su, DF; Su, FY; Wang, W; Zhang, H | 1 |
| Bekki, H; Fukami, K; Homma, T; Nakata, M; Nohara, M; Okuda, S; Sone, M; Yamagishi, S; Yamamoto, K | 1 |
| Johny, SK; Paul, D; Ravi, TK; Varghese, SJ | 1 |
| Jones, R; Lang, M; Neldam, S | 1 |
| Dahlöf, B; Guthrie, RM; Jamerson, KA; Oigman, W; Olvera, R; Schumacher, H; Seeber, M | 1 |
| Edwards, C; Jones, R; Neldam, S | 1 |
| Derosa, G; Fogari, R; Lazzari, P; Maffioli, P; Mugellini, A; Zoppi, A | 1 |
| Anabitarte-Prieto, A; Companioni, O; García-Bello, MA; Nóvoa-Mogollón, FJ; Plaza-Toledano, C; Rodríguez-Esparragón, F; Rodríguez-Pérez, JC; Suárez-Ortega, S | 1 |
| Fujishima, H; Fujita, H; Hosoba, M; Komatsu, K; Morii, T; Narita, T; Sakamoto, T; Takahashi, K; Takahashi, T; Yamada, Y | 1 |
| Suárez, C | 1 |
| Guthrie, RM | 1 |
| Deng, Q; Liu, L; Liu, M; Ma, L; Sun, H; Wang, J; Wang, W; Zhang, Y; Zhao, Y | 1 |
| Ehara, M; Habara, M; Ito, T; Kaneda, H; Kimura, M; Kinoshita, Y; Matsuo, H; Nasu, K; Rathore, S; Suzuki, T; Suzuki, Y; Tanaka, N; Terashima, M | 1 |
| Bakris, G; Kobe, M; Ley, L; Littlejohn, TW; Neutel, JM; Sharma, AM; Ting, N | 1 |
| Black, HR; Dahlöf, B; Defeo, H; Ley, L; Mancia, G; Neutel, JM; Vinisko, R | 1 |
| Derosa, G; Fogari, R; Maffioli, P; Mugellini, A; Perrone, T; Preti, P; Zoppi, A | 1 |
| Hirata, Y; Hishikari, K; Isobe, M; Masumura, M; Nagai, R; Nagashima, A; Ogawa, M; Shimizu, T; Suzuki, J; Takayama, K; Watanabe, R | 1 |
| Albarran, HA; Rodriguez, GC; Zeron, HM | 1 |
| Abe, M; Fujii, Y; Ito, M; Maruyama, N; Okada, K; Soma, M; Suzuki, H; Yoshida, Y | 1 |
| Bae, KS; Choi, HY; Jin, SJ; Kim, MJ; Kim, YH; Lim, HS; Lim, J; Noh, YH; Sung, HR | 1 |
| Dohi, Y; Kimura, G; Kojima, M; Ohashi, M | 1 |
| Dohi, K; Hiraoka, N; Hoshino, K; Ito, M; Kitai, T; Kumagai, N; Nakamori, S; Nakamura, M; Okamoto, S; Onishi, K; Oota, M; Ueda, Y; Yamada, T; Yazu, T | 1 |
| Dahlöf, B; Kobe, M; Majul, CR; Oigman, W; Olvera, R; Punzi, HA; Schumacher, H; Seeber, M; Webster, D | 1 |
| Ley, L; Schumacher, H | 1 |
| Chatzikyrkou, C; Menne, J | 1 |
| Goto, SN; Mizuno, Y; Takagi, H; Umemoto, T; Yamamoto, H | 1 |
| Bai, YY; Li, W; Liu, HQ; Lu, F; Ma, MM; Suo, AQ; Wang, JQ; Zhang, JW | 1 |
| Aoyama, T; Goto, M; Goto, N; Hiei, K; Iwasa, M; Kawai, N; Kida, K; Kobayashi, H; Kojima, S; Minagawa, T; Minatoguchi, S; Oda, M; Sugishita, F; Takai, K; Tanaka, R; Watanabe, I; Yamamoto, N; Yasue, T | 1 |
| Hayashi, N; Hirotani, A; Kamide, K; Katsuya, T; Kawai, T; Kitano, S; Nagano, M; Ohishi, M; Rakugi, H; Yamamoto, K | 1 |
| Daiber, A; Foster, C; Ghaemi Kerahrodi, J; Hausding, M; Jansen, T; Knorr, M; Kröller-Schön, S; Li, H; Mollnau, H; Münzel, T; Oelze, M; Schulz, E; Teutsch, C; Wenzel, P; Wu, Z; Zinßius, E | 1 |
| Biswas, E; Choudhury, H; Ghosh, B; Gorain, B; Halder, D; Pal, TK; Sarkar, AK; Sarkar, P | 1 |
| Billecke, SS; Marcovitz, PA | 1 |
| Sessa, WC; Siragusa, M | 1 |
| Ferro, A; Wierzbicki, AS | 1 |
| Dahlöf, B; Neldam, S; Oigman, W; Schumacher, H | 1 |
| Ruilope, LM; Segura, J | 1 |
| Akasaka, H; Miura, T; Saitoh, S; Shimamoto, K; Yoshida, H | 1 |
| Chen, JF; Huang, JX; Peng, GC; Sai, SQ; Wang, YF; Xiao, Y; Yang, Y; Ye, YL | 1 |
| Parati, G; Schumacher, H | 1 |
| Gao, P; Holtbruegge, W; Huang, C; Zhu, D | 1 |
| Sharma, K; Sweiss, N | 1 |
| Guggilla, R; Jan, S; Kallakuri, S; Maulik, PK; Naik, N; Patel, A; Prabhakaran, D; Rodgers, A; Salam, A; Selak, V; Singh, K; Thom, S; Webster, R | 1 |
| Barkhausen, J; Hübel, N; Mildner, M; Müller-Fielitz, H; Raasch, W; Vogt, FM | 1 |
| Abdel-Khalek, MM; Belal, TS; Daabees, HG; Khamis, MM; Mahrous, MS | 1 |
| Dolan, E; Ley, L; Parati, G; Schumacher, H | 1 |
| Izumikawa, Y; Kato, H; Kojima, K; Kubo, E; Nagura, M; Nosaka, H; Shima, T; Shimada, M; Shiraishi, T; Tanemoto, M; Tomioka, S; Uchida, S; Ueda, S; Yano, H | 1 |
| Chen, L; Hong, H; Lin, X; Shi, X; Wu, Y; Zou, G | 1 |
| Angeloni, E; Lombardo, P; Pirelli, M; Refice, S; Vitaterna, A | 1 |
| El Hassar, C; Malti, N; Merzouk, H; Merzouk, SA; Meziane, A; Narce, M | 1 |
| Lamie, NT; Mohamed, HM | 2 |
| Chen, XP; Li, HL; Wen, ZP; Yang, GP; Zhang, W; Zhang, ZL | 1 |
| Hirata, K; Ishida, T; Kondo, K; Mori, K; Toh, R; Yasuda, T | 1 |
| Aoki, H; Hoshide, S; Kario, K; Matsumoto, Y; Mizuno, H; Noshiro, T; Okazaki, O; Uchiyama, K; Yoshida, T | 1 |
| Guk, J; Heo, YA; Kim, Y; Park, K; Soh, D; Son, M; Woo Chae, D | 1 |
| Higaki, J; Ikeda, H; Komuro, I; Kuroki, D; Nishimura, S; Ogihara, T; Shiki, K; Taniguchi, A; Ugai, H | 1 |
| Bal, UA; Baysal, SS; Müderrisoğlu, H; Okyay, K; Öztuna, D; Pirat, B; Uluçam, MZ | 1 |
| Ahn, TH; Cho, EJ; Doh, JH; Ha, JW; Han, GR; Hyeon, MS; Im, SJ; Im, SW; Jae, JG; Kim, CH; Kim, HS; Kim, W; Lee, MM; Park, CG; Pyeon, WB; Ryu, JG; Tak, SJ; Yang, JY | 1 |
| Higaki, J; Ikeda, H; Komuro, I; Kuroki, D; Lee, G; Nishimura, S; Ogihara, T; Shiki, K; Taniguchi, A | 1 |
| Morishita, R; Taniyama, Y | 1 |
| Chen, XP; Li, HL; Luo, J; Shi, LH; Zhang, ZL; Zhao, JF; Zhu, MM | 1 |
| Kar, SK; Srivastava, A | 1 |
| Choi, DH; Kwon, SY; Lee, AR; Park, ES | 1 |
| Ahn, JC; Ahn, JH; Ahn, YK; Cha, DH; Chae, IH; Cho, DK; Cho, SK; Choi, YJ; Hong, SJ; Hong, TJ; Hyon, MS; Jang, JY; Jeon, DW; Jeong, JO; Kim, BS; Kim, HS; Kim, SH; Nam, CW; Oh, YS; Park, SH; Rha, SW; Song, JM; Sung, KC; Won, KH; Yang, TH; Yoo, BS; Yoo, KD; Yoon, YW | 1 |
| Choi, YK; Ghim, JL; Kim, EY; Oh, M; Park, SE; Shim, EJ; Shin, JG | 1 |
| Cho, HJ; Choi, DJ; Han, KR; Jo, SH; Kim, EJ; Kim, SJ; Park, JJ; Park, SJ; Shin, J; Shin, JH; Song, JM | 1 |
| Kang, SS; Kim, HJ; Kwon, YJ; Suh, GH | 1 |
| Amarasekara, S; Amarasena, N; Billot, L; de Silva, AP; de Silva, HA; Fernando, M; Guggilla, R; Jan, S; Jayawardena, J; Maulik, PK; Mendis, S; Munasinghe, J; Naik, N; Patel, A; Prabhakaran, D; Rajapakse, S; Ranasinghe, G; Rodgers, A; Salam, A; Selak, V; Senaratne, V; Stepien, S; Thom, S; Tisserra, N; Webster, R; Wijekoon, S; Wijeyasingam, S | 1 |
| Akabane, R; Konta, M; Miyagawa, Y; Nagakawa, M; Sakatani, A; Takemura, N | 1 |
| Ahn, Y; Chang, K; Cho, JM; Hong, SJ; Hyon, MS; Jeong, HS; Kang, WC; Kim, HS; Lee, JH; Pyun, WB | 1 |
| Ahn, JC; Cha, DH; Cho, SK; Jeon, DW; Kim, KH; Kim, SY; Kim, TS; Kim, WS; Kim, YJ; Lee, HC; Oh, YS; Park, DG; Park, SH; Rha, SW; Rhee, MY; Sung, KC; Yoo, BS; Yoo, KD; Yoon, MH; Yoon, YW | 1 |
| Habara, M; Haraguchi, T; Ikezaki, H; Kojima, H; Nakamura, S; Uchida, T; Yoshida, M | 1 |
| Chokalingam, K; Dhawan, S; Hiremath, JS; Mathan, G; Reddy, PNC; Sharma, A; Toppo, A | 1 |
| Jang, K; Jeon, JY; Kim, MG; Lim, Y; Moon, SJ; Yu, KS | 1 |
| Jeon, JY; Kim, MG; Moon, SJ; Yu, KS | 1 |
| Anireddy, J; Dongala, T; Palakurthi, AK; Yalavarthi, RK | 1 |
| Billot, L; de Silva, A; Guggilla, R; Jan, S; Maulik, PK; Mysore, J; Naik, N; Patel, A; Prabhakaran, D; Rodgers, A; Salam, A; Selak, V; Stepien, S; Thom, S; Wang, N; Webster, R | 1 |
| Ahn, JC; Chae, IH; Cho, EJ; Cho, JM; Cho, Y; Choi, SY; Han, KH; Hong, SJ; Hong, SP; Hwang, J; Hyon, MS; Jin, X; Kim, H; Kim, HS; Kim, JH; Kim, MH; Kim, PJ; Kim, WS; Kwon, K; Lee, H; Lee, HC; Lee, JH; Lee, K; Lee, SH; Park, CG; Rhee, MY; Seo, JS; Shin, JH; Sung, JH; Sung, KC; Yoo, BS | 1 |
| Hong, GR; Jo, SH; Kim, SW; Park, CG; Park, SJ | 1 |
| Akagi, Y; Aoyama, T; Enomoto, A; Hoshiko, M; Kawano, Y; Kujirai, A; Mano, Y; Nagata, M; Nakamatsu, S; Nakamura, S; Negishi, K; Nishikawa, T; Shimada, S; Suzuki, T; Tsukada, E | 1 |
| Attala, K; Elsonbaty, A | 1 |
| Feng, J; Gan, Y; Jiang, H; Ma, H | 1 |
| Agrawal, S; Anand, J; Bachani, D; Doshi, M; Gaikwad, VB; Halder, SK; Kinholkar, B; Kumar, DA; Kumbhar, A; Mathur, R; Mehta, S; Sarkar, G; Sharma, A | 1 |
| Desai, N; Jadhav, U; Kumar, GP; Muppalla, BS; Parthasaradhi, SV; Ram, CVS; Ray, S; Sawhney, JPS; Unni, G | 1 |
| Patel, A; Prajapati, P; Shah, S | 1 |
| Dragoi, EN; Erk, N; Joo, SW; Lotfy, HM; Mehmandoust, M; Tiris, G; Vasseghian, Y | 1 |
| Jat, R; Mistry, RP; Shah, C | 1 |
| Kang, TS; Kim, BK; Kim, JY; Lee, CJ; Lee, SH; Park, S; Sung, JH | 1 |
| Ahn, JC; Cho, EJ; Han, SH; Kang, SM; Kim, KH; Kim, KI; Kim, SY; Kim, W; Kim, YJ; Park, CG; Park, SJ; Park, SM; Shin, J; Shin, JH; Sohn, IS; Sung, JH; Sung, KC | 1 |
| Kassie, GM; Kerr, M; Moffat, A; Pratt, N; Roughead, EE | 1 |
| Cazabon, D; Hering, D; Krishna, A; Moran, AE; Pathni, AK; Sahoo, SK; Sharma, B | 1 |
| Cheng, YQ; Guo, PY; Liu, AJ; Shi, WT; Xia, T; Xu, LL | 1 |
| Liang, H; Tang, T; Xie, M | 1 |
| Ahn, Y; Cha, KS; Chang, K; Cho, EJ; Choi, DJ; Choi, SY; Doh, JH; Hong, SJ; Hong, SP; Hwang, JY; Hyon, MS; Ihm, SH; Kang, WC; Kim, HS; Kim, MH; Kim, SH; Kim, WS; Kim, YH; Kwon, K; Lee, JH; Lee, N; Lim, SW; Rhee, MY; Shin, J; Son, JW; Yoo, BS | 1 |
16 review(s) available for amlodipine and telmisartan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Importance of a fixed combination of telmisartan and amlodipine for the treatment of hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood; Cardiovascular Diseases; Clinical Trials as Topic; Drug Combinations; Humans; Hypertension; Risk Factors; Severity of Illness Index; Telmisartan | 2010 |
Evaluating 24-h antihypertensive efficacy by the smoothness index: a meta-analysis of an ambulatory blood pressure monitoring database.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Databases, Factual; Female; Humans; Losartan; Male; Ramipril; Randomized Controlled Trials as Topic; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2010 |
Telmisartan/amlodipine: single-pill combination in hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Clinical Trials as Topic; Drug Combinations; Humans; Hypertension; Telmisartan | 2010 |
Combination of telmisartan plus amlodipine in the treatment of hypertension: review of results.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypertension; Medication Adherence; Telmisartan; Treatment Outcome | 2010 |
Single-pill telmisartan and amlodipine: a rational combination for the treatment of hypertension.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Clinical Trials as Topic; Drug Combinations; Humans; Hypertension; Telmisartan | 2011 |
Review: a single-pill combination of telmisartan plus amlodipine for the treatment of hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypertension; Telmisartan; Treatment Outcome | 2011 |
Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients).
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Clinical Trials as Topic; Diabetes Complications; Humans; Hypertension; MEDLINE; Obesity; Risk Factors; Telmisartan | 2013 |
Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Confidence Intervals; Cross-Over Studies; Double-Blind Method; Humans; Hypertension; Hypertension, Renal; Imidazoles; Interleukin-6; Obesity; Prospective Studies; Publication Bias; Randomized Controlled Trials as Topic; Stents; Telmisartan; Tetrazoles; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2013 |
Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Humans; Hypertension; Patient Selection; Risk Factors; Telmisartan; Time Factors; Treatment Outcome | 2013 |
Early combination therapy with telmisartan plus amlodipine for rapid achievement of blood pressure goals.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Randomized Controlled Trials as Topic; Telmisartan; Treatment Outcome | 2013 |
A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide.
Topics: Administration, Oral; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Tablets; Telmisartan; Time Factors; Treatment Outcome | 2013 |
Blood pressure variability over 24 h: prognostic implications and treatment perspectives. An assessment using the smoothness index with telmisartan-amlodipine monotherapy and combination.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Drug Combinations; Drug Therapy, Combination; Humans; Hypertension; Prognosis; Telmisartan; Treatment Outcome | 2014 |
Adiponectin effects on the kidney.
Topics: Adiponectin; Albuminuria; Amlodipine; AMP-Activated Protein Kinases; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Humans; Kidney; Kidney Diseases; Mice; Obesity; Oxidative Stress; Perindopril; Renal Insufficiency, Chronic; Telmisartan | 2014 |
Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Calcium Channel Blockers; Humans; Hypertension; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Telmisartan | 2021 |
Efficacy of single-pill combination in uncontrolled essential hypertension: A systematic review and network meta-analysis.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Essential Hypertension; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Losartan; Network Meta-Analysis; Telmisartan; Tetrazoles; Valine; Valsartan | 2023 |
66 trial(s) available for amlodipine and telmisartan
| Article | Year |
|---|---|
Pharmacokinetics of repeated oral doses of amlodipine and amlodipine plus telmisartan in healthy volunteers.
Topics: Administration, Oral; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Calcium Channel Blockers; Cross-Over Studies; Drug Interactions; Female; Humans; Male; Middle Aged; Telmisartan | 2000 |
A comparison of the efficacy and duration of action of telmisartan, amlodipine and ramipril in patients with confirmed ambulatory hypertension.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Renin; Telmisartan; Therapeutic Equivalency | 2004 |
Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.
Topics: Adult; Aged; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Calcium Channel Blockers; Circadian Rhythm; Female; Humans; Hyperaldosteronism; Hypertension; Male; Middle Aged; Posture; Prospective Studies; Ramipril; Reference Values; Renin; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2005 |
Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Epinephrine; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Ramipril; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2005 |
Renal and vascular protective effects of telmisartan in patients with essential hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Endothelium, Vascular; Female; Heart Rate; Humans; Hypertension; In Vitro Techniques; Kidney; Male; Middle Aged; Telmisartan; Vasodilation | 2006 |
The effects of telmisartan and amlodipine on metabolic parameters and blood pressure in type 2 diabetic, hypertensive patients.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin Resistance; Middle Aged; PPAR gamma; Telmisartan | 2006 |
Effects of telmisartan on fat distribution in individuals with the metabolic syndrome.
Topics: Adipose Tissue, White; Adult; Aged; Amlodipine; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Aorta; Benzimidazoles; Benzoates; Biomarkers; Blood Glucose; Blood Pressure; Body Fat Distribution; Calcium Channel Blockers; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Resistance; Intra-Abdominal Fat; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Research Design; Telmisartan; Tomography, X-Ray Computed; Treatment Outcome; Vascular Resistance | 2007 |
Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria.
Topics: Adult; Aged; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan | 2007 |
Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stag
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cough; Diastole; Diet; Double-Blind Method; Drug Combinations; Edema; Exercise; Female; Headache; Humans; Hypertension; India; Male; Middle Aged; Prospective Studies; Systole; Telmisartan; Treatment Outcome | 2007 |
Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cholesterol; Chronic Disease; Creatinine; Female; Humans; Hypertension; Interleukin-6; Kidney Diseases; Male; Matrix Metalloproteinase 9; Middle Aged; Renal Insufficiency; Telmisartan; Triglycerides | 2008 |
Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study.
Topics: Amlodipine; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan | 2009 |
[Effects of Songling Xuemaikang Capsule on ambulatory blood pressure in treatment of essential hypertension: a single-blind randomized controlled trial].
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antineoplastic Agents; Benzimidazoles; Benzoates; Blood Pressure Monitoring, Ambulatory; Capsules; Drugs, Chinese Herbal; Female; Humans; Hypertension; Male; Middle Aged; Single-Blind Method; Telmisartan | 2009 |
Results of treatment with telmisartan-amlodipine in hypertensive patients.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Therapy, Combination; Edema; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2009 |
[Effects of amlodipine plus telmisartan or amlodipine plus amiloride regimen on blood pressure control in hypertensive patients: preliminary report of Chinese Hypertension Intervention Efficacy (CHIEF) trial].
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan | 2009 |
[Perindopril, amlodipine and telmisartan improve arterial stiffness in patients with hypertension].
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Brachial Artery; Female; Humans; Hypertension; Male; Middle Aged; Perindopril; Telmisartan; Vascular Resistance | 2009 |
The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics.
Topics: Aged; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Chi-Square Distribution; China; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Kaplan-Meier Estimate; Male; Middle Aged; Research Design; Risk Assessment; Risk Factors; Telmisartan; Time Factors; Treatment Outcome | 2011 |
Treatment of hypertension: postmarketing surveillance study results of telmisartan monotherapy, fixed dose combination of telmisartan + hydrochlorothiazide/amlodipine.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; India; Male; Middle Aged; Telmisartan; Treatment Outcome | 2009 |
Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2010 |
Differential effect of telmisartan and amlodipine on monocyte chemoattractant protein-1 and peroxisome proliferator-activated receptor-gamma gene expression in peripheral monocytes in patients with essential hypertension.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Chemokine CCL2; Female; Gene Expression; Humans; Hypertension; Male; Middle Aged; Monocytes; PPAR gamma; Severity of Illness Index; Telmisartan | 2011 |
Effects of manidipine and its combination with an ACE inhibitor on insulin sensitivity and metabolic, inflammatory and prothrombotic markers in hypertensive patients with metabolic syndrome: the MARCADOR study.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Dihydropyridines; Drug Combinations; Female; Humans; Hypertension; Insulin Resistance; Lisinopril; Male; Metabolic Syndrome; Middle Aged; Nitrobenzenes; Piperazines; Prospective Studies; Spain; Telmisartan | 2011 |
Beneficial cardiometabolic actions of telmisartan plus amlodipine therapy in elderly patients with poorly controlled hypertension.
Topics: Adiponectin; Age Factors; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Drug Substitution; Drug Therapy, Combination; Female; Humans; Hypertension; Japan; Male; Prospective Studies; Telmisartan; Tetrazoles; Time Factors; Treatment Outcome; Up-Regulation; Valine; Valsartan | 2011 |
Telmisartan and amlodipine single-pill combinations vs amlodipine monotherapy for superior blood pressure lowering and improved tolerability in patients with uncontrolled hypertension: results of the TEAMSTA-5 study.
Topics: Adult; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Drug Substitution; Drug Synergism; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2011 |
Efficacy and tolerability of telmisartan plus amlodipine in added-risk hypertensive patients.
Topics: Adult; Age Factors; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Risk Factors; Telmisartan | 2011 |
Switching patients with uncontrolled hypertension on amlodipine 10 mg to single-pill combinations of telmisartan and amlodipine: results of the TEAMSTA-10 study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2011 |
Effect of telmisartan addition to amlodipine on ankle edema development in treating hypertensive patients.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Ankle; Antihypertensive Agents; Benzimidazoles; Benzoates; Cross-Over Studies; Drug Combinations; Edema; Female; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Telmisartan | 2011 |
Anti-albuminuric effects of the angiotensin AT1 receptor blocker telmisartan in hypertensive patients.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Diabetic Nephropathies; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Male; Middle Aged; Prospective Studies; Sulfonamides; Telmisartan; Torsemide; Treatment Outcome | 2011 |
Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
Topics: Aged; Amiloride; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; China; Diuretics; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prospective Studies; Risk Factors; Telmisartan; Time Factors; Treatment Outcome | 2012 |
Protective effect of telmisartan against endothelial dysfunction after coronary drug-eluting stent implantation in hypertensive patients.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Chi-Square Distribution; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Endothelium, Vascular; Female; Humans; Hypertension; Male; Statistics as Topic; Statistics, Nonparametric; Telmisartan; Vasoconstriction | 2012 |
Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Severity of Illness Index; Telmisartan; Treatment Outcome | 2012 |
Single-pill combination of telmisartan/amlodipine in patients with severe hypertension: results from the TEAMSTA severe HTN study.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Likelihood Functions; Male; Middle Aged; Severity of Illness Index; Telmisartan | 2012 |
Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Fibrillation; Benzimidazoles; Benzoates; Calcium Channel Blockers; Double-Blind Method; Female; Heart Atria; Humans; Hypertension; Male; Recurrence; Risk Factors; Telmisartan | 2012 |
Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Albuminuria; Aldosterone; Amides; Amlodipine; Angiotensin II Type 2 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fatty Acid-Binding Proteins; Female; Fumarates; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Male; Middle Aged; Renin; Telmisartan; Young Adult | 2012 |
Pharmacokinetic interaction of telmisartan with s-amlodipine: an open-label, two-period crossover study in healthy Korean male volunteers.
Topics: Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Area Under Curve; Benzimidazoles; Benzoates; Calcium Channel Blockers; Chromatography, Liquid; Cross-Over Studies; Drug Interactions; Follow-Up Studies; Humans; Male; Republic of Korea; Stereoisomerism; Tandem Mass Spectrometry; Telmisartan; Time Factors; Young Adult | 2012 |
Titration of telmisartan, but not addition of amlodipine, reduces urine albumin in diabetic patients treated with telmisartan-diuretic.
Topics: Adult; Aged; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome | 2013 |
The effects of telmisartan and amlodipine in treatment-naïve and previously treated hypertensive patients: a subanalysis from a 4 × 4 factorial design study.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2013 |
[Effects of telmisartan on the level of Aβ1-42, interleukin-1β, tumor necrosis factor α and cognition in hypertensive patients with Alzheimer's disease].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amlodipine; Amyloid beta-Peptides; Antihypertensive Agents; Benzimidazoles; Benzoates; Cognition; Female; Humans; Hypertension; Interleukin-1beta; Male; Middle Aged; Peptide Fragments; PPAR gamma; Telmisartan; Tumor Necrosis Factor-alpha | 2012 |
Comparative effect of candesartan and amlodipine, and effect of switching from valsartan, losartan, telmisartan and olmesartan to candesartan, on early morning hypertension and heart rate.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Drug Substitution; Female; Heart Rate; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Prospective Studies; Telmisartan; Tetrazoles; Valine; Valsartan | 2013 |
Effect of tablets with a combination of telmisartan and amlodipine on patients with hypertension: the Cotalo study.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Drug Combinations; Epinephrine; Female; Humans; Hypertension; Male; Middle Aged; Tablets; Telmisartan | 2013 |
A comparative pharmacokinetic study of a fixed dose combination for essential hypertensive patients: a randomized crossover study in healthy human volunteers.
Topics: Adolescent; Adult; Amlodipine; Benzimidazoles; Benzoates; Cross-Over Studies; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Hypoglycemic Agents; Middle Aged; Telmisartan | 2013 |
Comparative effects of telmisartan and valsartan as add-on agents for hypertensive patients with morning blood pressure insufficiently controlled by amlodipine monotherapy.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Chemical Analysis; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Endpoint Determination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Sleep; Telmisartan; Tetrazoles; Valine; Valsartan | 2014 |
[Blood pressure lowering efficacy of telmisartan and amlodipine taking on the morning or at bedtime: ABPM results].
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure Monitoring, Ambulatory; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan | 2013 |
A randomized, double-blind study to evaluate the efficacy and safety of a single-pill combination of telmisartan 80 mg/amlodipine 5 mg versus amlodipine 5 mg in hypertensive Asian patients.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2014 |
TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol.
Topics: Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Prospective Studies; Severity of Illness Index; Telmisartan; Treatment Outcome | 2014 |
Comparison of telmisartan/amlodipine and telmisartan/hydrochlorothiazide in the treatment of Japanese patients with uncontrolled hypertension: the TAT-Kobe study.
Topics: Aged; Aged, 80 and over; Amlodipine; Benzimidazoles; Benzoates; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Japan; Male; Middle Aged; Prospective Studies; Telmisartan | 2016 |
Dose Timing of an Angiotensin II Receptor Blocker/Calcium Channel Blocker Combination in Hypertensive Patients With Paroxysmal Atrial Fibrillation.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Circadian Rhythm; Drug Combinations; Female; Humans; Hypertension; Male; Natriuretic Peptide, Brain; Prospective Studies; Telmisartan; Treatment Outcome | 2016 |
Pharmacokinetic Interaction Between Rosuvastatin, Telmisartan, and Amlodipine in Healthy Male Korean Subjects: A Randomized, Open-label, Multiple-dose, 2-period Crossover Study.
Topics: Adult; Amlodipine; Area Under Curve; Asian People; Benzimidazoles; Benzoates; Cross-Over Studies; Drug Combinations; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Rosuvastatin Calcium; Tablets; Telmisartan; Young Adult | 2016 |
The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Hypertension; Japan; Male; Middle Aged; Telmisartan; Treatment Outcome | 2017 |
Treatment-associated change in apelin concentration in patients with hypertension and its relationship with left ventricular diastolic function.
Topics: Amlodipine; Antihypertensive Agents; Apelin; Biomarkers; Case-Control Studies; Echocardiography; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome; Ventricular Dysfunction, Left | 2017 |
Comparison of the Efficacy and Safety of Fixed-dose S-Amlodipine/Telmisartan and Telmisartan in Hypertensive Patients Inadequately Controlled with Telmisartan: A Randomized, Double-blind, Multicenter Study.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan | 2016 |
Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2017 |
Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI St
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dizziness; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Essential Hypertension; Female; Headache; Humans; Hydrochlorothiazide; Male; Middle Aged; Telmisartan; Treatment Outcome; Young Adult | 2018 |
Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers.
Topics: Administration, Oral; Adult; Amlodipine; Benzimidazoles; Benzoates; Cross-Over Studies; Dose-Response Relationship, Drug; Healthy Volunteers; Humans; Male; Maximum Tolerated Dose; Middle Aged; Tablets; Telmisartan; Young Adult | 2017 |
S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chlorthalidone; Clinical Trials, Phase IV as Topic; Diuretics; Double-Blind Method; Drug Combinations; Drug Resistance; Equivalence Trials as Topic; Female; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Republic of Korea; Telmisartan; Time Factors; Treatment Outcome; Young Adult | 2018 |
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Chlorthalidone; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hypertension; Male; Medication Adherence; Middle Aged; Potassium; Sri Lanka; Telmisartan | 2018 |
Efficacy and Safety of Triple Therapy With Telmisartan, Amlodipine, and Rosuvastatin in Patients With Dyslipidemia and Hypertension: The Jeil Telmisartan, Amlodipine, and Rosuvastatin Randomized Clinical Trial.
Topics: Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Hypertension; Male; Middle Aged; Republic of Korea; Rosuvastatin Calcium; Telmisartan | 2019 |
Efficacy and Tolerability of Telmisartan/Amlodipine and Rosuvastatin Coadministration in Hypertensive Patients with Hyperlipidemia: A Phase III, Multicenter, Randomized, Double-blind Study.
Topics: Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Double-Blind Method; Drug Combinations; Female; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Rosuvastatin Calcium; Telmisartan; Treatment Outcome | 2019 |
A Randomized, Double-blinded, Controlled, Multicentre Phase III Study to Evaluate the Efficacy and Safety of Telmisartan /Amlodipine/Hydrochlorothiazide Compared to Telmisartan/Hydrochlorothiazide in Patients with Essential Hypertension.
Topics: Amlodipine; Antihypertensive Agents; Drug Combinations; Drug Therapy, Combination; Essential Hypertension; Humans; Hydrochlorothiazide; Telmisartan | 2018 |
Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects.
Topics: Administration, Oral; Adult; Amlodipine; Cohort Studies; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Tolerance; Healthy Volunteers; Humans; Male; Middle Aged; Republic of Korea; Rosuvastatin Calcium; Telmisartan; Young Adult | 2019 |
Pharmacokinetic Interaction Among Telmisartan, Amlodipine, and Hydrochlorothiazide After a Single Oral Administration in Healthy Male Subjects.
Topics: Administration, Oral; Adult; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Drug Interactions; Healthy Volunteers; Humans; Hydrochlorothiazide; Male; Middle Aged; Telmisartan; Young Adult | 2019 |
Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH Trial.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Dose-Response Relationship, Drug; Drug Prescriptions; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Retrospective Studies; Telmisartan; Treatment Outcome | 2020 |
Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia.
Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Hypertension; Male; Middle Aged; Rosuvastatin Calcium; Telmisartan | 2020 |
Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study.
Topics: Adult; Amlodipine; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Coronary Artery Disease; Drug Therapy, Combination; Essential Hypertension; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Metoprolol; Telmisartan; Tetrazoles | 2022 |
Achieving the Latest American Heart Association and American College of Cardiology Therapeutic Goals for Hypertension With Combination Therapy and Its Effects on Blood Pressure and Central Hemodynamic Parameters.
Topics: American Heart Association; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Calcium; Calcium Channel Blockers; Cardiology; Drug Therapy, Combination; Goals; Humans; Hypertension; Prospective Studies; Pulse Wave Analysis; Telmisartan; Treatment Outcome; United States | 2022 |
Effects of high-intensity statin combined with telmisartan versus amlodipine on glucose metabolism in hypertensive atherosclerotic cardiovascular disease patients with impaired fasting glucose: A randomized multicenter trial.
Topics: Amlodipine; Atherosclerosis; Cardiovascular Diseases; Fasting; Glucose; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Insulin Resistance; Prediabetic State; Rosuvastatin Calcium; Telmisartan | 2022 |
Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trial.
Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Essential Hypertension; Humans; Hypertension; Telmisartan; Treatment Outcome | 2022 |
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trial.
Topics: Aged; Amlodipine; Chlorthalidone; Essential Hypertension; Female; Humans; Hypertension; Leukemia, Myeloid, Acute; Male; Middle Aged; Telmisartan | 2023 |
54 other study(ies) available for amlodipine and telmisartan
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Angiotensin II receptor blockers downsize adipocytes in spontaneously type 2 diabetic rats with visceral fat obesity.
Topics: Adipocytes; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Glucose; Calcium Channel Blockers; Cell Size; Diabetes Mellitus, Type 2; Disease Models, Animal; Insulin; Intra-Abdominal Fat; Male; Obesity; PPAR gamma; Random Allocation; Rats; Rats, Long-Evans; Telmisartan; Tetrazoles; Valine; Valsartan | 2007 |
Effect of telmisartan and amlodipine on home blood pressure by monitoring newly developed telemedicine system: monitoring test by using telemedicine. Telmisartan's effect on home blood pressure (TelTelbosu).
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cell Phone; Female; Humans; Hypertension; Internet; Male; Middle Aged; Self Care; Telemedicine; Telemetry; Telmisartan | 2008 |
A stunning day in hypertension research - Results of ONTARGET, ACCOMPLISH and HYVET.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Benzimidazoles; Benzoates; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Ramipril; Telmisartan | 2008 |
Increased transient receptor potential canonical type 3 channels in vasculature from hypertensive rats.
Topics: Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Benzimidazoles; Benzoates; Blood Pressure; Calcium; Calcium Channel Blockers; Cells, Cultured; Gene Expression Regulation; Hypertension; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Telmisartan; TRPC Cation Channels; Vasoconstrictor Agents | 2009 |
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growt
Topics: Acrylates; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Enalapril; Humans; Imidazoles; Indazoles; Lisinopril; Male; Mice; Mice, SCID; Neoplasms; Nifedipine; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Ramipril; Rats; Rats, Sprague-Dawley; Telmisartan; Thiophenes; Xenograft Model Antitumor Assays | 2009 |
Evaluation of safety and efficacy of telmisartan-amlodipine combination in treating hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Diabetes Complications; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Prospective Studies; Telmisartan; Treatment Outcome | 2008 |
Effect of switching from amlodipine to combination therapy with telmisartan and low-dose hydrochlorothiazide.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Body Mass Index; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome; Uric Acid | 2009 |
Increased rhythmicity in hypertensive arterial smooth muscle is linked to transient receptor potential canonical channels.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Boron Compounds; Calcium; Calcium Channels; Hypertension; Imidazoles; In Vitro Techniques; Muscle, Smooth, Vascular; Norepinephrine; Periodicity; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Telmisartan; Tetrazoles; TRPC Cation Channels; Verapamil | 2010 |
New drug information: Twynsta 40 mg/5mg.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Drug Combinations; Humans; Hypertension; Telmisartan | 2010 |
A third amlodipine/ARB combination (Twynsta) for hypertension.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Drug Combinations; Humans; Hypertension; Telmisartan; Treatment Outcome | 2010 |
Disparate effects of eplerenone, amlodipine and telmisartan on podocyte injury in aldosterone-infused rats.
Topics: Albuminuria; Aldosterone; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Benzimidazoles; Benzoates; Blotting, Western; Calcium Channel Blockers; Eplerenone; Immunoenzyme Techniques; Kidney Glomerulus; Male; Membrane Proteins; Mineralocorticoid Receptor Antagonists; Podocytes; Proteinuria; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spironolactone; Telmisartan | 2011 |
[Fixed combination of telmisartan and amlodipine. Lowering blood pressure with dual power].
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Combinations; Germany; Humans; Hypertension; Medication Adherence; Telmisartan | 2010 |
Synergism of telmisartan and amlodipine on blood pressure reduction and cardiorenal protection in hypertensive rats.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Hypertension; Kidney; Kidney Diseases; Kidney Glomerulus; Male; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Telmisartan; Time Factors | 2011 |
In vitro interaction study of retinoic acid isomers with telmisartan and amlodipine by equilibrium dialysis method using UV spectroscopy.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Dialysis; Drug Interactions; Isomerism; Isotretinoin; Protein Binding; Serum Albumin, Bovine; Spectrophotometry, Ultraviolet; Telmisartan; Tretinoin | 2011 |
Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2(Akita) diabetic mice.
Topics: Acetophenones; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Chemical Analysis; Blood Glucose; Blotting, Western; Diabetes Mellitus; Diabetic Nephropathies; Dinoprostone; Enzyme Inhibitors; Hyperglycemia; Immunohistochemistry; Kidney; Male; Mice; Mice, Inbred C57BL; NADPH Oxidases; NF-E2-Related Factor 2; Superoxide Dismutase; Superoxides; Telmisartan | 2012 |
Different roles of PPAR-γ activity on physiological and pathological alteration after myocardial ischemia.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cells, Cultured; Disease Models, Animal; Drug Partial Agonism; Fibrosis; Hypertrophy, Left Ventricular; Male; Matrix Metalloproteinase 2; Myocardial Infarction; Myocardium; Pioglitazone; PPAR gamma; Rats; Rats, Sprague-Dawley; Stroke Volume; Telmisartan; Thiazolidinediones; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2012 |
Hemodynamic evaluation and anti-hypertensive schemes used in puerperal women following pre-eclampsia.
Topics: Adolescent; Adult; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Catheterization, Swan-Ganz; Drug Therapy, Combination; Eclampsia; Electric Impedance; Female; Furosemide; Hemodynamics; Humans; Nitroprusside; Postpartum Period; Prazosin; Pre-Eclampsia; Pregnancy; Telmisartan; Young Adult | 2012 |
Improving drug adherence using fixed combinations caused beneficial treatment outcomes and decreased health-care costs in patients with hypertension.
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Health Care Costs; Humans; Hypertension; Male; Medication Adherence; Middle Aged; Prospective Studies; Retrospective Studies; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2013 |
Targeting albuminuria in arterial hypertension and diabetes: how is it best achieved and what is its clinical relevance?
Topics: Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Female; Humans; Hypertension; Male; Telmisartan | 2013 |
Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats.
Topics: Amlodipine; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Experimental; Drug Combinations; Endothelium, Vascular; Male; Organ Culture Techniques; Oxidative Stress; Rats; Rats, Wistar; Telmisartan; Treatment Outcome | 2013 |
Telmisartan exerts pleiotropic effects in endothelial cells and promotes endothelial cell quiescence and survival.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Apoptosis; Benzimidazoles; Benzoates; Blood Proteins; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Combinations; Endothelial Cells; Enzyme Inhibitors; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Hypertension; Ketocholesterols; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins c-akt; Signal Transduction; Telmisartan | 2013 |
Lower, faster, better: the delusions of surrogate markers in hypertension.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Drug Combinations; Female; Humans; Hypertension; Male; Telmisartan | 2013 |
Chronic blockade of angiotensin AT₁ receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Obesity Agents; Antihypertensive Agents; Behavior, Animal; Benzimidazoles; Benzoates; Diet, High-Fat; Dietary Sucrose; Drug Therapy, Combination; Energy Intake; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Obesity; Random Allocation; Rats; Rats, Inbred SHR; Telmisartan; Weight Gain | 2014 |
Validated spectrofluorimetric determination of two pharmaceutical antihypertensive mixtures containing amlodipine besylate together with either candesartan cilexetil or telmisartan.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Chemistry, Pharmaceutical; Molecular Structure; Spectrometry, Fluorescence; Telmisartan; Tetrazoles | 2014 |
Impact of antihypertensive combination and monotreatments on blood pressure variability: assessment by old and new indices. Data from a large ambulatory blood pressure monitoring database.
Topics: Adult; Aged; Algorithms; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Clinical Trials as Topic; Databases, Factual; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Reproducibility of Results; Severity of Illness Index; Telmisartan; Treatment Outcome | 2014 |
Blood pressure control and satisfaction of hypertensive patients following a switch to combined drugs of an angiotensin receptor blocker and a calcium channel blocker in clinical practice of nephrology.
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Azetidinecarboxylic Acid; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Drug Combinations; Drug Costs; Drug Substitution; Female; Humans; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Nephrology; Patient Satisfaction; Practice Patterns, Physicians'; Renal Insufficiency, Chronic; Retrospective Studies; Surveys and Questionnaires; Telmisartan; Tetrazoles; Valsartan | 2015 |
TRPC1, CaN and NFATC3 signaling pathway in the pathogenesis and progression of left ventricular hypertrophy in spontaneously hypertensive rats.
Topics: Amlodipine; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Disease Models, Animal; Disease Progression; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; NFATC Transcription Factors; Rats; Rats, Inbred SHR; Signal Transduction; Telmisartan; TRPC Cation Channels | 2015 |
Single-pill combination therapy in the initial treatment of marked hypertension: a propensity-matched analysis.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Perindopril; Propensity Score; Ramipril; Retrospective Studies; Risk Factors; Telmisartan; Tetrazoles | 2015 |
Long-term use of angiotensin II receptor antagonists and calcium-channel antagonists in Algerian hypertensive patients: effects on metabolic and oxidative parameters.
Topics: Algeria; Amlodipine; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Calcium Channel Blockers; Female; Humans; Hypertension; Male; Middle Aged; Oxidative Stress; Telmisartan | 2015 |
Application and validation of superior spectrophotometric methods for simultaneous determination of ternary mixture used for hypertension management.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Drug Combinations; Hydrochlorothiazide; Hypertension; Spectrophotometry; Tablets; Telmisartan | 2016 |
Influence of G-protein β-Polypeptide 3 C825T Polymorphism on Antihypertensive Response to Telmisartan and Amlodipine in Chinese Patients.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Essential Hypertension; Female; Genotype; Heterotrimeric GTP-Binding Proteins; Humans; Hypertension; Male; Middle Aged; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Telmisartan | 2016 |
Analytical Eco-Scale for Assessing the Greenness of a Developed RP-HPLC Method Used for Simultaneous Analysis of Combined Antihypertensive Medications.
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Chromatography, High Pressure Liquid; Drug Combinations; Green Chemistry Technology; Humans; Hydrochlorothiazide; Molecular Structure; Telmisartan | 2016 |
Are diuretic additives fit for uncontrolled hypertensive patients receiving telmisartan and amlodipine treatment?
Topics: Amlodipine; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diuretics; Drug Combinations; Humans; Hypertension; Telmisartan; Treatment Outcome | 2017 |
Influence of PRKCH gene polymorphism on antihypertensive response to amlodipine and telmisartan.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Arterial Pressure; Asian People; Benzimidazoles; Benzoates; Essential Hypertension; Female; Heart Rate; Heterozygote; Homozygote; Humans; Male; Middle Aged; Polymorphism, Genetic; Protein Kinase C; Telmisartan | 2017 |
Attributions to new onset catatonic symptoms, late in the course of chronic schizophrenia.
Topics: Amlodipine; Antihypertensive Agents; Antipsychotic Agents; Aripiprazole; Catatonia; Chronic Disease; GABA Modulators; Humans; Hydrochlorothiazide; Lorazepam; Male; Middle Aged; Schizophrenia; Telmisartan; Time | 2017 |
Quality by Design (QbD) approach to optimize the formulation of a bilayer combination tablet (Telmiduo
Topics: Amlodipine; Animals; Benzimidazoles; Benzoates; Chemistry, Pharmaceutical; Dogs; Drug Combinations; Male; Tablets; Telmisartan; Therapeutic Equivalency | 2017 |
Successful management of proteinuria and systemic hypertension in a dog with renal cell carcinoma with surgery, telmisartan, and amlodipine.
Topics: Amlodipine; Animals; Antihypertensive Agents; Carcinoma, Renal Cell; Dog Diseases; Dogs; Hypertension; Kidney Neoplasms; Male; Nephroureterectomy; Proteinuria; Telmisartan | 2018 |
Evaluation of the inhibitory effects of telmisartan on drug-induced renin-angiotensin-aldosterone system activation in normal dogs.
Topics: Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Dogs; Female; Heart Rate; Renin-Angiotensin System; Telmisartan | 2018 |
A new strategy for taste masking on bitter drug by other combined drug in fixed-dose combination: bitterness of Amlodipine besylate could be masked efficiently by Valsartan.
Topics: Amlodipine; Benzazepines; Captopril; Dose-Response Relationship, Drug; Humans; Hydrochlorothiazide; Taste; Taste Perception; Telmisartan; Valsartan | 2019 |
QbD-based development of an extraction procedure for simultaneous quantification of telmisartan, amlodipine besylate and chlorthalidone in combination complex matrix formulation.
Topics: Amlodipine; Chlorthalidone; Chromatography, High Pressure Liquid; Drug Combinations; Limit of Detection; Linear Models; Reproducibility of Results; Research Design; Tablets; Telmisartan | 2020 |
Telmisartan Plus S-Amlodipine Single-Pill Combination Therapy is Safe and Effective in Patients with Hypertension from Large-Scale Nationwide Surveillance Data in Korea (NOVEL) Study.
Topics: Amlodipine; Antihypertensive Agents; Benzoates; Blood Pressure; Drug Combinations; Drug Therapy, Combination; Humans; Hypertension; Republic of Korea; Telmisartan; Treatment Outcome | 2021 |
Comprehensive Exploration of Medications That Affect the Bleeding Risk of Oral Anticoagulant Users.
Topics: Administration, Oral; Administrative Claims, Healthcare; Amlodipine; Anticoagulants; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B; Bisoprolol; Case-Control Studies; Drug Interactions; Female; Hemorrhage; Humans; Japan; Male; Middle Aged; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Telmisartan; Warfarin | 2021 |
Advanced eco-friendly UV spectrophotometric approach for resolving overlapped spectral signals of antihypertensive agents in their binary and tertiary pharmaceutical dosage form.
Topics: Amlodipine; Antihypertensive Agents; Hydrochlorothiazide; Spectrophotometry; Tablets; Telmisartan | 2021 |
Simultaneous Estimation of Telmisartan, Chlorthalidone, Amlodipine Besylate and Atorvastatin by RP-HPLC Method for Synchronous Assay of Multiple FDC Products Using Analytical FMCEA-Based AQbD Approach.
Topics: Amlodipine; Atorvastatin; Chlorthalidone; Chromatography, High Pressure Liquid; Telmisartan | 2023 |
Simultaneous determination of hydrochlorothiazide, amlodipine, and telmisartan with spectrophotometric and HPLC green chemistry applications.
Topics: Amlodipine; Chromatography, High Pressure Liquid; Humans; Hydrochlorothiazide; Leukemia, Myeloid, Acute; Telmisartan | 2022 |
RP-HPLC method development and validation for simultaneous estimation of telmisartan, rosuvastatin calcium, and amlodipine besylate in combination.
Topics: Amlodipine; Antihypertensive Agents; Chromatography, High Pressure Liquid; Humans; Hypertension; Rosuvastatin Calcium; Telmisartan | 2022 |
Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary Care.
Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Amlodipine; Amphotericin B; Australia; Case-Control Studies; Ciprofloxacin; Diclofenac; Furosemide; Humans; Ibuprofen; Metformin; Naproxen; Omeprazole; Primary Health Care; Ramipril; Simvastatin; Spironolactone; Sulfamethoxazole; Telmisartan; Trimethoprim; Valacyclovir; Zoledronic Acid | 2022 |
Financial implications of protocol-based hypertension treatment: an insight into medication costs in public and private health sectors in India.
Topics: Amlodipine; Chlorthalidone; Humans; Hypertension; India; Private Sector; Telmisartan | 2023 |
Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo.
Topics: Amlodipine; Animals; Antihypertensive Agents; Blood Pressure; Hypotension; Rats; Rats, Inbred SHR; Telmisartan | 2023 |